Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Efficacy and safety of febuxostat extended release and immediate release in patients with gout and moderate renal impairment: phase II placebo-controlled studyArthritis research & therapy, 2018-05, Vol.20 (1), p.99-99, Article 99 [Peer Reviewed Journal]COPYRIGHT 2018 BioMed Central Ltd. ;Copyright © 2018. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and conditions, you may use this content in accordance with the terms of the License. ;The Author(s). 2018 ;ISSN: 1478-6362 ;ISSN: 1478-6354 ;EISSN: 1478-6362 ;DOI: 10.1186/s13075-018-1593-0 ;PMID: 29848361Full text available |
|
2 |
Material Type: Article
|
Cardiovascular Safety of Febuxostat or Allopurinol in Patients with GoutThe New England journal of medicine, 2018-03, Vol.378 (13), p.1200-1210 [Peer Reviewed Journal]Copyright © 2018 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1710895 ;PMID: 29527974Full text available |
|
3 |
Material Type: Article
|
Pyramid Registry: An Observational Study of Adalimumab in Crohnʼs Disease: Results at Year Five: 1682The American journal of gastroenterology, 2013-10, Vol.108, p.S506 [Peer Reviewed Journal]ISSN: 0002-9270 ;EISSN: 1572-0241 ;DOI: 10.14309/00000434-201310001-01682Full text available |
|
4 |
Material Type: Article
|
Long-term Effectiveness of Adalimumab in Crohnʼs Disease: Observational Data from the PYRAMID Registry: 1804The American journal of gastroenterology, 2013-10, Vol.108, p.S543-S544 [Peer Reviewed Journal]ISSN: 0002-9270 ;EISSN: 1572-0241 ;DOI: 10.14309/00000434-201310001-01804Full text available |
|
5 |
Material Type: Article
|
Induction of Remission with Adalimumab in Patients with Moderate Crohnʼs Disease: Subanalysis of CLASSIC I: 1166The American journal of gastroenterology, 2011-10, Vol.106, p.S436-S437 [Peer Reviewed Journal]ISSN: 0002-9270 ;EISSN: 1572-0241 ;DOI: 10.14309/00000434-201110002-01166Full text available |
|
6 |
Material Type: Article
|
Elevated C-reactive Protein in Anti-TNF-Naïve Patients is Associated with Higher Remission Rates: 1167The American journal of gastroenterology, 2011-10, Vol.106, p.S437 [Peer Reviewed Journal]ISSN: 0002-9270 ;EISSN: 1572-0241 ;DOI: 10.14309/00000434-201110002-01167Full text available |
|
7 |
Material Type: Article
|
Efficacy and Safety of Adalimumab in Moderate Compared with Severe Crohnʼs Disease: Pooled Data from the CHARM and EXTEND Trials: 1163The American journal of gastroenterology, 2011-10, Vol.106, p.S434-S435 [Peer Reviewed Journal]ISSN: 0002-9270 ;EISSN: 1572-0241 ;DOI: 10.14309/00000434-201110002-01163Full text available |
|
8 |
Material Type: Article
|
Baseline C-Reactive Protein is Associated With Disease Progression in Patients with Crohnʼs Disease: 1164The American journal of gastroenterology, 2011-10, Vol.106, p.S435 [Peer Reviewed Journal]ISSN: 0002-9270 ;EISSN: 1572-0241 ;DOI: 10.14309/00000434-201110002-01164Full text available |
|
9 |
Material Type: Article
|
Risk of Malignancy, Infection, Serious Infection, and Acute Health Care Use in Patients With Crohnʼs Disease Treated With Adalimumab vs. Immunosuppressants: 1599The American journal of gastroenterology, 2012-10, Vol.107, p.S646 [Peer Reviewed Journal]ISSN: 0002-9270 ;EISSN: 1572-0241 ;DOI: 10.14309/00000434-201210001-01599Full text available |
|
10 |
Material Type: Patent
|
Foot-stabilizing shoe insertsDigital Resources/Online E-Resources |